National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 467 cases where Vaccine targets Measles (MEA or MER or MM or MMR or MMRV) and Patient Died and Vaccination Date on/before '2018-11-30'

Case Details

This is page 24 out of 47

Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next


VAERS ID: 494837 (history)  
Form: Version 1.0  
Age: 4.0  
Sex: Female  
Location: Michigan  
Vaccinated:2013-05-15
Onset:2013-05-15
   Days after vaccination:0
Submitted: 2013-06-21
   Days after onset:37
Entered: 2013-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPV: DTAP + IPV (KINRIX) / GLAXOSMITHKLINE BIOLOGICALS AC20B204AA / 5 LL / IM
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. H015624 / 2 LL / SC

Administered by: Public       Purchased by: Public
Symptoms: Death, Pulmonary aplasia
SMQs:, Congenital, familial and genetic disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-05-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Ventolin 90 mcg QID, glycopyrrolate 0.5mg QID, montelukast 4mg qHS, nitrofurantoin 25mg qHS, Flovent 11mcg BID
Current Illness: Multiple congenital abnormalities-see below
Preexisting Conditions: Chronic Respiratory Disease, Tracheal Anomoly, Sleep Apnea, Hydronephrosis, Polydactyly, esophogeal abnormalities, uretal obstruction
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Unknown-patient died at home on 5/15/13. Time of death not indicated on death certificate. Manner of death indicated as natural and pulmonary aplasia listed as cause of death.


VAERS ID: 495494 (history)  
Form: Version 1.0  
Age: 1.13  
Sex: Male  
Location: Texas  
Vaccinated:2010-06-07
Onset:2010-06-11
   Days after vaccination:4
Submitted: 2013-06-30
   Days after onset:1115
Entered: 2013-06-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
BCG: BCG (MYCOBAX) / SANOFI PASTEUR - / 1 GM / SYR
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. - / 1 LG / SYR

Administered by: Unknown       Purchased by: Public
Symptoms: Haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-06-30
   Days after onset: 1115
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions: Cephalhematoma
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Vaccine recipient started to bleed on both hands and walked over a filled bathtub.


VAERS ID: 503021 (history)  
Form: Version 1.0  
Age: 1.08  
Sex: Female  
Location: New Mexico  
Vaccinated:2013-07-10
Onset:2013-07-30
   Days after vaccination:20
Submitted: 2013-09-18
   Days after onset:50
Entered: 2013-09-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS AHAVB692AA / 1 UN / UN
HIBV: HIB (PEDVAXHIB) / MERCK & CO. INC. J000564 / 4 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (VIRIVAC) / MERCK & CO. INC. H009578 / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH G45476 / 4 UN / UN
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. H017132 / UNK UN / UN

Administered by: Unknown       Purchased by: Public
Symptoms: Adenovirus infection, Alpha 1 foetoprotein normal, Amino acid level, Ammonia decreased, Anaemia, Anti-NMDA antibody negative, Antibody test, Antibody test negative, Antinuclear antibody negative, Aspergillus test, Asthenia, B-lymphocyte count, B-lymphocyte count decreased, Bacterial infection, Biopsy skin abnormal, Blood creatine phosphokinase decreased, Blood culture negative, Blood fibrinogen increased, Blood fibrinogen normal, Blood homocysteine normal, Blood immunoglobulin A normal, Blood immunoglobulin E, Blood immunoglobulin G normal, Blood immunoglobulin M increased, Blood lactate dehydrogenase increased, Blood lactic acid decreased, Blood lactic acid normal, Blood pyruvic acid, Blood pyruvic acid increased, Blood triglycerides increased, Blood urea, Bordetella test negative, Bronchial secretion retention, CD4 lymphocytes decreased, CD4/CD8 ratio, CD8 lymphocytes decreased, CSF culture negative, CSF oligoclonal band absent, CSF test abnormal, CSF test normal, Carnitine decreased, Cell marker, Cerebral atrophy, Ceruloplasmin, Chlamydia test negative, Clostridium test, Clostridium test negative, Complement factor, Corynebacterium test, Culture negative, Culture urine negative, Culture wound negative, Culture wound positive, Cytomegalovirus test, Cytomegalovirus test negative, Diarrhoea, Encephalopathy, Endotracheal intubation, Enterovirus test negative, Enzyme level test, Epstein-Barr virus test negative, Free fatty acids, Fungal test, Fungal test negative, General physical health deterioration, Gram stain positive, HIV test negative, Herpes simplex serology negative, Herpes virus infection, Human herpes virus 6 serology negative, Human rhinovirus test positive, Immunoglobulin therapy, Influenza B virus test, Influenza virus test negative, Intensive care, Jaundice, Klebsiella infection, Klebsiella test positive, Legionella test, Lipids, Lumbar puncture abnormal, Lymphocyte stimulation test, Measles antibody negative, Mumps antibody test, Muscular weakness, Mycoplasma test, Natural killer cell count, Nervous system disorder, Neurological decompensation, Nuclear magnetic resonance imaging brain abnormal, Nuclear magnetic resonance imaging spinal abnormal, Organic acid analysis, Parasite stool test negative, Polymerase chain reaction, Pseudomonas infection, Rash papular, Rhinovirus infection, Rubella antibody test, Scab, Serum ferritin increased, Stool analysis normal, T-lymphocyte count decreased, Thyroxine decreased, Transfusion, Tuberculin test negative, Urine analysis normal, Varicella virus test positive, Viral test negative, Vitamin B12, Warm type haemolytic anaemia, White matter lesion
SMQs:, Rhabdomyolysis/myopathy (broad), Cholestasis and jaundice of hepatic origin (narrow), Haemolytic disorders (narrow), Acute pancreatitis (broad), Angioedema (broad), Dyslipidaemia (narrow), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (narrow), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Dementia (broad), Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypothyroidism (broad), Hyperthyroidism (broad), Lipodystrophy (broad), Normal pregnancy conditions and outcomes (broad), Skin tumours of unspecified malignancy (broad), Chronic kidney disease (broad), Hypersensitivity (broad), Noninfectious diarrhoea (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2013-10-03
   Days after onset: 65
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 48 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Surface Marker T&B panel CD3 (T3): 18% (low) CD3 ABS: 58 (low) Surface marker CD4 (T4): 12% (low) Surface Marker T4 ABs: 40 (low) CD8 (T8): 5% (low) T8 ABS: 16 (low) CD4/CD8 ratio: 2.54 (nl) CD19 (B4): 68% (high) CD19 Abs: 225 (low) CD16/CD56 NK cells 15% (high nl) CD16/CD56 Absolute count 49 (low) IgA: 32 IgG 505 IgM 309 (high) IgE: 49.9 (nl 0-49) CH50: 25 (reference values have not been established for patients <16 yo) AH50: not done LDH: 2586 Ferritin: 1310 Fibrinogen: 337 Triglycerides: 150 Ammonia: 15 Lactate: 1.39 CK: <20 Stool reducing substances negative ANA profile negative Carnitine profile: total carnitine low (30) otherwise normal Pyruvic acid, B: 0.17 (high; nl 0.08-0.16) Pyruvic acid (mg/dL): 1.5 (high, nl 0.7-1.4) Homocysteine: 4.8 (nl 4.7-12.6) Alpha-fetoprotein: 2.1 Ceruloplasmin: 19.4 CSF and serum paraneoplastic lab: negative CSF and serum NMDA receptor antibody: negative Oligoclonal bands (CSF): negative 3 Methylglutaconic acid: normal Organic acid (urine): "slight 3-hydroxyisovaleric without 3-methylcrotonylglycine; rule out biotin deficiency or combined carboxylase deficiency" Total lipids: 680 Pending labs: Very long chain fatty acid Complete MTDNA analysis Lysosomal enzyme panel Plasmalogen Urine organic acid Plasma amino acids Acylcarnitine profile Vitamin B12 metabolites UPGC (testing for congenital porphyria) Lymphocyte stimulation CD31 recent thymic emigrants cytochip 5 cell (CGL) Pyridoxal 5-phosphate Folate/5MTHF (CSF) BH4/Neopterin profile (CSF) Amino acid (CSF) Toll-like receptor assay B-cell line immortalized with EBV Comprehensive SCID panel, 18 genes Vaccine antibodies: Rubeola virus IgM and IgG: negative S. Pneumoniae IgG Ab: All 23 serotype IgG levels low Diphtheria IgG: 0.020 (minimum level of protective antibody is 0.01-0.1; majority should demonstrate $g0.1) Tetanus IgG: 0.11 (minimum level of protective antibody 0.01-0.15; majority should demonstrate $g0.15) H. Influenzae B Ab IgG: 0.56 (reference .0.15; optimum antibody level is $g1.0 post vaccine) Microbiology: BAL studies: Pneumocystis stain: negative Gram stain: gram positive organism identified HSV and CMV negative Pertussis negative Mycoplasma negative Fungal culture negative Chlamydia trachomatis negative Mycoplasma negative Legionella negative Pending: M. Hominis and ureaplasma VZV studies: 9/4 CSF VZV PCR: positive; 723 copies/ml 9/12 CSF VZV PCR: pending VZV PCR (wound swab 9/12): positive, 137,156 copies/ml VZV PCR (2nd skin wound 9/12): in-process VZV PCR from BAL fluid: pending VZV PCR from serum:negative VZV IgM (serum): negative VZV IgG (serum): positive VZV IgM and IgG from CSF and serum: negative Other micro: Viral PCR: adenovirus, rhino/entero Urine culture (9/4): $g100,000 colonies Klebsiella Urine culture (9/11): no growth CSF studies: culture NGTD, EBV, CMV, HSV negative Blood cultures (9/4): NGTD Blood fungus culture (9/5): negative Stool wet mount: negative C diff: negative Stool O&P: negative Stool viral EM: negative Wound culture (9/6): rare normal skin flora isolated HHV6 PCR (serum): negative HHV-6 PCR (CSF): not done CMV (urine): negative Measles PCR (throat) negative Mumps PCR (thorat) in-process Rubella PCR (throat) in-process Parvo PCR (CSF): not done Aspergillus antigen: pending Enterovirus PCR (CSF): negative Enterovirus PCR (throat, rectum): negative HIV-1 DNA PCR: negative PPD skin test: negative
CDC Split Type:

Write-up: Patient presented to urgent care on 8/1/13 with 2 day history of diarrhea, possible fever, decreased energy, and jaundice. She also developed a disseminated flesh colored papular rash which would rapidly scab over. She was found to be profoundly anemic to 5.4 and was admitted to hospital. She required nearly daily transfusions due to new onset warm Ab hemolytic anemia which only improved slightly with a burst of high dose steroids as well as two treatments with IVIG. She also developed three other rashes during this hospital course. She had a massive diagnostic workup at Hospital, and had a skin biopsy of a lesion that appeared to be consistent with a herpes virus infection but was negative for HSV1 or HSV2. She was treated with IV acyclovir at meningitic dosing for 14 days. She also developed worsening encephalopathy with decreased ability to clear her own secretions. It was determined that she was deteriorating clinically and required further diagnostic workup at a tertiary care center. She was transferred to another hospital on 9/4/13. She was admitted to the PICU due to worsening neurologic status and has required prolonged intubation due to concern for neuromuscular weakness. LP on admission and subsequent skin lesion sample was positive for VZV DNA by PCR, and MRI brain and neck has shown diffuse cerebral atrophy and hyperintensity of basal ganglia, medulla, and cervical spine. She was treated with a burst of high dose steroids and 3 back-to-back doses of IVIG with improvement in her transfusion requirements. She was also treated with acyclovir and subsequently foscarnet with improvement in symptoms. Of note, she has had multiple infections during her hospital courses including rhinovirus, adenovirus, Pseudomonas, Ambiotrophia, and Klebsiella.


VAERS ID: 537090 (history)  
Form: Version 1.0  
Age: 1.51  
Sex: Male  
Location: Tennessee  
Vaccinated:2014-07-11
Onset:2014-07-12
   Days after vaccination:1
Submitted: 2014-07-14
   Days after onset:2
Entered: 2014-07-21
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS T3PM5 / 4 RL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. J006955 / 1 RA / SC
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. J006693 / 1 LA / SC

Administered by: Private       Purchased by: Private
Symptoms: Autopsy, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2014-07-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Possible viral illness; low grade fever
Preexisting Conditions: 32 wk preemie
Allergies:
Diagnostic Lab Data: Autopsy was performed.
CDC Split Type:

Write-up: Child found dead the next morning by family member.


VAERS ID: 546331 (history)  
Form: Version 1.0  
Age: 1.26  
Sex: Male  
Location: Tennessee  
Vaccinated:2014-08-27
Onset:2014-09-24
   Days after vaccination:28
Submitted: 2014-10-03
   Days after onset:9
Entered: 2014-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS T3PMS / 4 LL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. J006955 / 1 RA / SC
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. J009728 / 1 LA / SC

Administered by: Private       Purchased by: Private
Symptoms: Autopsy, Cardiac arrest, Death, Irritability, Respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Cardiomyopathy (broad), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2014-09-24
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: Parents C/o "fussy"
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy pending results.
CDC Split Type:

Write-up: Was at daycare - had taken nap/aroused fussy - consoled/but then noted not breathing 911 - to ER/dx with cardiac arrest ELLD.


VAERS ID: 563453 (history)  
Form: Version 1.0  
Age: 1.06  
Sex: Male  
Location: Iowa  
Vaccinated:2014-11-10
Onset:2014-11-17
   Days after vaccination:7
Submitted: 2015-01-30
   Days after onset:74
Entered: 2015-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. K004856 / 1 LL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. J000202 / 1 RL / SC
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. K002921 / 1 LL / SC

Administered by: Private       Purchased by: Unknown
Symptoms: Autopsy, Intestinal ischaemia, Intestinal malrotation, Volvulus
SMQs:, Congenital, familial and genetic disorders (narrow), Gastrointestinal obstruction (narrow), Ischaemic colitis (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2014-11-17
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol and PULMICORT Neb; SINGULAIR; AURALGAN drops
Current Illness: Cough; recurrent OM
Preexisting Conditions: Hypotonia; Pneumonia H/O; Recurrent OM; Delayed developmental milestone
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Midgut volvulus with bowel ischemia due to intestinal malrotation per autopsy report.


VAERS ID: 566311 (history)  
Form: Version 1.0  
Age: 1.14  
Sex: Female  
Location: Georgia  
Vaccinated:2015-02-19
Onset:2015-02-19
   Days after vaccination:0
Submitted: 2015-02-20
   Days after onset:1
Entered: 2015-02-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS E443F / 2 LL / IM
HIBV: HIB (PEDVAXHIB) / MERCK & CO. INC. K008878 / 2 LL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. K002528 / 1 RA / SC
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH J16883 / 2 RL / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. K011797 / 1 RL / SC

Administered by: Unknown       Purchased by: Public
Symptoms: Death, Resuscitation
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2015-02-19
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Levalbuterol 0.63 mg prn; ipratropium 0.2% bid via nebulizer; belcomethasone 40 mcg via spacer bid
Current Illness: None
Preexisting Conditions: G-tube dependent; history of pulmonary hypertension arthrogryposis; clinodactyly; polyhydramnios, single umbibical artery; macrocepaly, enlarged (L) kidney, Piere Robin Sequence, congenital hip dislocation; single umbilical artery; chronic resp. failure; anomaly of vertebrae, congenital anamaly of ribs and sterum; small but restrictive PDA; (L) aortic arch w/berrant (r) subclavian artery.
Allergies:
Diagnostic Lab Data: n/a
CDC Split Type:

Write-up: Patient had alarms last night (02/19/2015), mother tried to stimulate and called 911. EMT''s arrived and began transport to hospital, but patient arrested and was not able to be resuscitated in ED.


VAERS ID: 566447 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-02-23
Entered: 2015-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1502USA008840

Write-up: Information has been received from a consumer referring to 109 patients of unknown age and gender. The patients'' concurrent condition and medical history not reported. The reporter had concerned about the patients were vaccinated with M-M-R II (lot#, dose and route not reported) and (3) live neurotoxin vaccines (manufacturer unknown) (strength, dose, lot# and route were not reported) were given in combination on unknown dates could create adverse effects. Concomitant therapy was not provided. On unknown dates, the patients died from the M-M-R II. It was not confirmed if autopsies were performed or not. The cause of death was unknown. Consumer could not confirm where he received this statistic. Additional information has been requested.


VAERS ID: 569399 (history)  
Form: Version 1.0  
Age: 3.0  
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-03-13
Entered: 2015-03-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Generalised tonic-clonic seizure, Immediate post-injection reaction
SMQs:, Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1503USA005208

Write-up: This spontaneous report as received from a consumer refers to her cousin, an approximately 3 years old male patient. On an unknown date, in early 1990''s the patient was vaccinated with M-M-R II, (therapy type HSA, dose and Lot# were not reported). On an unknown date, immediately after vaccination, the patient experienced general grand mal seizures that continued to worsen throughout a one year period. On an unknown date, when the patient was having up to 40 seizures a day, he was admitted to a hospital. On an unknown date, reported as one year after vaccination with M-M-R II the patient died. The cause of death was reported as seizure. Relatedness between grand mal seizure and M-M-R II was not reported. Upon internal review general grand mal seizures were considered to be medically significant. Additional information has been requested.


VAERS ID: 573366 (history)  
Form: Version 1.0  
Age: 1.16  
Sex: Male  
Location: Michigan  
Vaccinated:2008-07-01
Onset:2008-07-02
   Days after vaccination:1
Submitted: 2015-04-09
   Days after onset:2472
Entered: 2015-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C2950AA / 3 RL / IM
HIBV: HIB (ACTHIB) / SANOFI PASTEUR UF263AC / 3 LL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0215X / 1 RL / SC
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1076U / 1 LL / SC

Administered by: Unknown       Purchased by: Other
Symptoms: Autopsy, Blood test, Decreased appetite, Diet refusal, Fatigue, Irritability, Pyrexia, Toxicologic test
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2008-07-04
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: difficulty breathing~DTaP + HepB + IPV (no brand name)~2~0.42~Patient|difficulty breathing~DTaP + HepB + IPV (no brand name)~~0.
Other Medications: Albuterol
Current Illness: No
Preexisting Conditions: Tentative diagnosis of childhood asthma
Allergies:
Diagnostic Lab Data: Blood work from 07/01/2008; Autopsy protocol and toxicology
CDC Split Type:

Write-up: Irritability, fatigue, loss of appetite, fever, refusing to drink.


Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=24&VAX[]=MEA&VAX[]=MER&VAX[]=MM&VAX[]=MMR&VAX[]=MMRV&VAXTYPES[]=Measles&DIED=Yes&VAX_YEAR_HIGH=2018&VAX_MONTH_HIGH=11


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166